Roche’s combo lymphoma treatment wins U.S. FDA approval

53

The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG’s antibody-drug conjugate Polivy for treatment of patients with advanced lymphoma.

http://feeds.reuters.com/~r/reuters/healthNews/~3/ul1WEDenQuU/roches-combo-lymphoma-treatment-wins-u-s-fda-approval-idUSKCN1TB25S